JP2023549360A5 - - Google Patents
Info
- Publication number
- JP2023549360A5 JP2023549360A5 JP2023528245A JP2023528245A JP2023549360A5 JP 2023549360 A5 JP2023549360 A5 JP 2023549360A5 JP 2023528245 A JP2023528245 A JP 2023528245A JP 2023528245 A JP2023528245 A JP 2023528245A JP 2023549360 A5 JP2023549360 A5 JP 2023549360A5
- Authority
- JP
- Japan
- Prior art keywords
- represented
- bicyclic
- nitrogen
- bonded
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063113515P | 2020-11-13 | 2020-11-13 | |
| US63/113,515 | 2020-11-13 | ||
| PCT/US2021/059168 WO2022104079A1 (en) | 2020-11-13 | 2021-11-12 | Pyrazolo[1,5-a]pyrazine derivatives as btk inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023549360A JP2023549360A (ja) | 2023-11-24 |
| JP2023549360A5 true JP2023549360A5 (https=) | 2024-11-15 |
| JP7839790B2 JP7839790B2 (ja) | 2026-04-02 |
Family
ID=78828007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023528245A Active JP7839790B2 (ja) | 2020-11-13 | 2021-11-12 | Ｂｔｋ阻害剤としてのピラゾロ［１，５－ａ］ピラジン誘導体 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20240083900A1 (https=) |
| EP (1) | EP4244223A1 (https=) |
| JP (1) | JP7839790B2 (https=) |
| KR (1) | KR20230119134A (https=) |
| CN (1) | CN116783199A (https=) |
| AR (1) | AR124048A1 (https=) |
| AU (1) | AU2021377891A1 (https=) |
| BR (1) | BR112023009116A2 (https=) |
| CL (1) | CL2023001367A1 (https=) |
| CO (1) | CO2023007677A2 (https=) |
| MX (1) | MX2023005626A (https=) |
| TW (1) | TW202233624A (https=) |
| UY (1) | UY39517A (https=) |
| WO (1) | WO2022104079A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023086575A1 (en) * | 2021-11-12 | 2023-05-19 | Biogen Ma Inc. | Btk inhibitors |
| KR20250005229A (ko) | 2022-05-04 | 2025-01-09 | 하. 룬드벡 아크티에셀스카브 | 모노아실글리세롤 리파제 억제제로서 1,1,1,3,3,3-헥사플루오로프로판-2-일 (s)-1-(피리다진-3-일카르바모일)-6 아자스피로[2.5]옥탄-6-카르복실레이트의 결정질 형태 |
| JP2025515728A (ja) * | 2022-05-10 | 2025-05-20 | バイオジェン・エムエイ・インコーポレイテッド | Ｎ－メチル－Ｎ－（（１ｓ，３ｓ）－３－メチル－３－（（６－（１－メチル－１Ｈ－ピラゾール－４－イル）ピラゾロ［１，５－ａ］ピラジン－４－イル）オキシ）シクロブチル）アクリルアミドの結晶多形 |
| WO2024083111A1 (zh) * | 2022-10-18 | 2024-04-25 | 首药控股(北京)股份有限公司 | 一种新型杂环化合物 |
| WO2024117205A1 (ja) * | 2022-11-30 | 2024-06-06 | 北興化学工業株式会社 | 双環式ピリジン誘導体およびその塩、並びに、当該誘導体又はその塩を有効成分として含有することを特徴とする有害生物防除剤 |
| CN116693357B (zh) * | 2023-06-07 | 2026-01-27 | 西安工程大学 | 一种β-三氟甲基不饱和酰胺及其合成方法 |
| WO2025049254A1 (en) * | 2023-08-25 | 2025-03-06 | Juno Therapeutics, Inc. | Pyrazolopyridine based inhibitors of dna-dependent protein kinase and compositions and application in gene editing |
| CN118955332A (zh) * | 2024-07-31 | 2024-11-15 | 德阳悦合生物医药科技有限公司 | 一种作为医药中间体的化合物叔丁基甲基(3-酮环丁基)氨基甲酸酯的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2266908C (en) * | 1996-09-27 | 2010-07-20 | Joseph E. Saavedra | O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates |
| JP2001302667A (ja) | 2000-04-28 | 2001-10-31 | Bayer Ag | イミダゾピリミジン誘導体およびトリアゾロピリミジン誘導体 |
| CN103987713A (zh) | 2011-10-12 | 2014-08-13 | 阵列生物制药公司 | 5,7-取代的咪唑并[1,2-c]嘧啶 |
| RS58361B1 (sr) * | 2013-07-31 | 2019-03-29 | Merck Patent Gmbh | Piridini, pirimidini i pirazini, kao inhibitori btk i njihova upotreba |
| WO2015157955A1 (en) * | 2014-04-17 | 2015-10-22 | Abbvie Inc. | Heterocyclic btk inhibit ors |
| WO2020114487A1 (en) * | 2018-12-07 | 2020-06-11 | Sunshine Lake Pharma Co., Ltd. | Ret inhibitors, pharmaceutical compositions and uses thereof |
| EP3898626A1 (en) | 2018-12-19 | 2021-10-27 | Array Biopharma, Inc. | Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of fgfr tyrosine kinases |
| JP2025515728A (ja) * | 2022-05-10 | 2025-05-20 | バイオジェン・エムエイ・インコーポレイテッド | Ｎ－メチル－Ｎ－（（１ｓ，３ｓ）－３－メチル－３－（（６－（１－メチル－１Ｈ－ピラゾール－４－イル）ピラゾロ［１，５－ａ］ピラジン－４－イル）オキシ）シクロブチル）アクリルアミドの結晶多形 |
-
2021
- 2021-11-12 EP EP21823425.0A patent/EP4244223A1/en active Pending
- 2021-11-12 AR ARP210103131A patent/AR124048A1/es unknown
- 2021-11-12 AU AU2021377891A patent/AU2021377891A1/en active Pending
- 2021-11-12 BR BR112023009116A patent/BR112023009116A2/pt unknown
- 2021-11-12 UY UY0001039517A patent/UY39517A/es unknown
- 2021-11-12 US US18/036,853 patent/US20240083900A1/en active Pending
- 2021-11-12 KR KR1020237019845A patent/KR20230119134A/ko active Pending
- 2021-11-12 CN CN202180089379.6A patent/CN116783199A/zh active Pending
- 2021-11-12 TW TW110142205A patent/TW202233624A/zh unknown
- 2021-11-12 MX MX2023005626A patent/MX2023005626A/es unknown
- 2021-11-12 WO PCT/US2021/059168 patent/WO2022104079A1/en not_active Ceased
- 2021-11-12 JP JP2023528245A patent/JP7839790B2/ja active Active
-
2023
- 2023-05-11 CL CL2023001367A patent/CL2023001367A1/es unknown
- 2023-06-13 CO CONC2023/0007677A patent/CO2023007677A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023549360A5 (https=) | ||
| KR102858043B1 (ko) | Il-12, il-23 및/또는 ifn-알파의 조정과 관련된 상태의 치료를 위한 아미드-치환된 헤테로시클릭 화합물 | |
| KR102702228B1 (ko) | 술폰 피리딘 알킬 아미드-치환된 헤테로아릴 화합물 | |
| US8569294B2 (en) | 2-(cyclic amino)-pyrimidone derivatives | |
| KR101787858B1 (ko) | 야누스-관련된 키나아제의 억제제로서의 피롤로 [2,3-d]피리미딘 유도체 | |
| CN115715287A (zh) | 作为IL-12、IL-23和/或IFNα调节剂的经取代的N-(甲基-d3)哒嗪-3-甲酰胺或N-(甲基-d3)-烟酰胺化合物 | |
| JP2007510689A5 (https=) | ||
| US9586961B2 (en) | Homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof | |
| JP2014528433A5 (https=) | ||
| WO2015193846A1 (en) | Substituted indazole compounds as irak4 inhibitors | |
| JP2008528467A5 (https=) | ||
| EA035036B1 (ru) | Производные пиразоло[1,5-а]пиразин-4-ила в качестве ингибиторов янус-киназы (jak) | |
| JP2016526576A5 (https=) | ||
| AU2009316019A1 (en) | Heterocyclically substituted aryl compounds as HIF inhibitors | |
| UA121658C2 (uk) | Сполуки 5-хлордифторметоксифенілпіразолопіримідину як інгібітори янус-кінази | |
| JP2017511357A5 (https=) | ||
| CA2564629A1 (en) | Substituted phenylaminopyrimidines | |
| US20230121086A1 (en) | RORgT INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF | |
| HUP9801575A2 (hu) | 1,3-Dihidro-1-(fenil-alkil)-2H-imidazol-2-on származékok alkalmazása PDE IV és citokin hatású gyógyszerkészítmények előállítására, új 1,3-dihidro-1-(fenil-alkil)-2H-imidazol-2-on-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmé.. | |
| US20220235032A1 (en) | Bisheterocyclic carbonyl substituted dihydropyrazole compound, preparation method therefor and pharmaceutical use thereof | |
| US20250171417A1 (en) | Heterocyclic derivative, and composition and pharmaceutical use thereof | |
| CA3215410A1 (en) | 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and medical uses thereof | |
| CN103619354A (zh) | 止痒剂 | |
| JP2023533003A5 (https=) | ||
| US9868724B2 (en) | Compounds |